ARCHIVES

Revlimid Plus Steroid Effective In Clinical Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 11 | November 30, 2007

Download PDF Visit The Full Archive

Related Articles

Boyd’s Rebuttal to DePinho’s Letter to the AAUP

May 30, 2014

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

September 26, 2014

Community Cancer Centers Selected For Pilot Program.

June 22, 2007

$2.5 Million NCI Grant To Fund Brachytherapy Improvement

February 27, 2004

May issue of Business & Regulatory Report, 8 additional pages, included.

May 28, 2004

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014